Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease

• Status: Completed
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to explore the recurrence risk of cardiovascular events in patients with type 2 diabetes mellitus and coronary heart disease after different antidiabetic drug therapy (glipizide or metformin) by using an double-blind, randomized, parallel control and prospective study

The end point of this study is:

1. follow up 3yr

2. recurrence of cardiovascular event

3. death caused by other reasons such as stroke, uremia, blindness and amputation

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai Jiao Tong University School of Medicine
• Treatments: Glipizide; Hypoglycemic Agents; Metformin

Criteria

Inclusion Criteria:

• Coronary heart disease

• Type 2 diabetes

Exclusion Criteria:

• Severe organ dysfunction, psychopathy, infection, neutropenia

• Congenital heart disease, rheumatic heart disease, severe arrhythmia, myocardiopathy